دورية أكاديمية

The value of tirofiban in non⁃macrovascular occlusive ischemic stroke beyond time window

التفاصيل البيبلوغرافية
العنوان: The value of tirofiban in non⁃macrovascular occlusive ischemic stroke beyond time window
المؤلفون: Xing⁃chen ZHOU, Han⁃sheng SHU, Da⁃wei WANG, Hui ZHANG, Hao WANG, Guang YANG, Jing⁃liang MIN
المصدر: Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 20, Iss 8, Pp 740-745 (2020)
بيانات النشر: Tianjin Huanhu Hospital, 2020.
سنة النشر: 2020
المجموعة: LCC:Neurology. Diseases of the nervous system
مصطلحات موضوعية: stroke, brain ischemia, platelet aggregation inhibitors, Neurology. Diseases of the nervous system, RC346-429
الوصف: Objective To observe the clinical value of early application of tirofiban in patients with non⁃macrovascular occlusive ischemic stroke beyondtime window. Methods Clinicaldata of90 patients with non⁃macrovascular occlusive ischemic stroke treated beyond time window from April 2017 to April 2019 were retrospectively analyzed. According to different treatment, they were dividedinto 2 groups,one group given tirofiban combined with double antibody treatment (treatment group, 50 cases) and another group given double antibody treatment only (control group, 40 cases). National Institutes of Health Stroke Scale (NIHSS) was used to evaluate the neurological status of patients on the 1st, 3rd and 7th day of treatment. On the day of admission and 3 months after treatment, modified Rankin Scale (mRS) and Activities of Daily Living Scale (ADL) were used to evaluate the neurological recovery and activities of daily living. The occurrence of bleeding and severe thrombocytopenia (platelet count
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Chinese
تدمد: 1672-6731
العلاقة: http://www.cjcnn.org/index.php/cjcnn/article/view/2199Test; https://doaj.org/toc/1672-6731Test
الوصول الحر: https://doaj.org/article/2e14408d27d04dd0bf00fffe1e4b8f70Test
رقم الانضمام: edsdoj.2e14408d27d04dd0bf00fffe1e4b8f70
قاعدة البيانات: Directory of Open Access Journals